Table 3

PCR corrected clinical and parasitological failure at day 45 by treatment.

Treatment outcome n/N (%)

SP

AL

OR (95% CI)

P-value

ETF

25/465 (6.4)

2/462 (0.5)

13.1 (3.08–55.50)

<0.001

LCF

33/391 (8.4)

14/404 (3.5)

2.55 (1.34–4.84)

0.004

LPF

18/391 (4.6)

6/404 (1.5)

3.18 (1.25–8.09)

0.02

TTF (PCR corrected)

76/391 (19.3)

22/404 (5.4)

4.15 (2.52–6.83)

<0.001

Mulenga et al. Malaria Journal 2006 5:73   doi:10.1186/1475-2875-5-73